105 related articles for article (PubMed ID: 17476595)
1. False-positive findings for tumor markers after curative gastrectomy for gastric cancer.
Ohtsuka T; Sato S; Kitajima Y; Tanaka M; Nakafusa Y; Miyazaki K
Dig Dis Sci; 2008 Jan; 53(1):73-9. PubMed ID: 17476595
[TBL] [Abstract][Full Text] [Related]
2. Different roles of tumor marker monitoring after curative resections of gastric and colorectal cancers.
Ohtsuka T; Nakafusa Y; Sato S; Kitajima Y; Tanaka M; Miyazaki K
Dig Dis Sci; 2008 Jun; 53(6):1537-43. PubMed ID: 17932750
[TBL] [Abstract][Full Text] [Related]
3. The role of gastric distention in differentiating recurrent tumor from physiologic uptake in the remnant stomach on 18F-FDG PET.
Yun M; Choi HS; Yoo E; Bong JK; Ryu YH; Lee JD
J Nucl Med; 2005 Jun; 46(6):953-7. PubMed ID: 15937305
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of early postoperative tumor marker response in gastric cancer.
Nam DH; Lee YK; Park JC; Lee H; Shin SK; Lee SK; Lee YC; Cheong JH; Hyung WJ; Noh SH; Kim CB
Ann Surg Oncol; 2013 Nov; 20(12):3905-11. PubMed ID: 23807661
[TBL] [Abstract][Full Text] [Related]
5. Follow-up after curative resection for gastric cancer: Is it time to tailor it?
Aurello P; Petrucciani N; Antolino L; Giulitti D; D'Angelo F; Ramacciato G
World J Gastroenterol; 2017 May; 23(19):3379-3387. PubMed ID: 28596674
[TBL] [Abstract][Full Text] [Related]
6. Combined epithelial-mesenchymal transition with cancer stem cell-like marker as predictors of recurrence after radical resection for gastric cancer.
Xu GF; Zhang WJ; Sun Q; Xu X; Zou X; Guan W
World J Surg Oncol; 2014 Dec; 12():368. PubMed ID: 25441488
[TBL] [Abstract][Full Text] [Related]
7. Role of serum tumor markers in monitoring for recurrence of gastric cancer following radical gastrectomy.
Choi SR; Jang JS; Lee JH; Roh MH; Kim MC; Lee WS; Qureshi W
Dig Dis Sci; 2006 Nov; 51(11):2081-6. PubMed ID: 17009116
[TBL] [Abstract][Full Text] [Related]
8. The relationships between perioperative CEA, CA 19-9, and CA 72-4 and recurrence in gastric cancer patients after curative radical gastrectomy.
Kim DH; Oh SJ; Oh CA; Choi MG; Noh JH; Sohn TS; Bae JM; Kim S
J Surg Oncol; 2011 Nov; 104(6):585-91. PubMed ID: 21695697
[TBL] [Abstract][Full Text] [Related]
9. Elevated high-sensitivity C-reactive protein, a marker of advanced stage gastric cancer and postgastrectomy disease recurrence.
Woo Y; Hyung WJ; Obama K; Kim HI; Pak KH; Son T; Noh SH
J Surg Oncol; 2012 Mar; 105(4):405-9. PubMed ID: 22025360
[TBL] [Abstract][Full Text] [Related]
10. Suture granuloma with false-positive finding on PET/CT after gastrectomy for gastric cancer.
Tsujita E; Ikeda Y; Kinjo N; Yamashita Y; Kumagai R; Taguchi K; Yamaguchi S; Minami K; Yamamoto M; Morita M; Toh Y; Okamura T
Asian J Endosc Surg; 2015 Nov; 8(4):457-60. PubMed ID: 26708585
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of detecting symptomatic or asymptomatic recurrence in patients with gastric cancer after a curative gastrectomy.
Bilici A; Salman T; Oven Ustaalioglu BB; Unek T; Seker M; Aliustaoglu M; Gezen C; Unek T; Yavuzer D; Unlu M; Gumus M; Yilmaz U
J Surg Res; 2013 Mar; 180(1):e1-9. PubMed ID: 22520575
[TBL] [Abstract][Full Text] [Related]
12. Recurrence following laparoscopy-assisted gastrectomy for gastric cancer: a multicenter retrospective analysis of 1,417 patients.
Song J; Lee HJ; Cho GS; Han SU; Kim MC; Ryu SW; Kim W; Song KY; Kim HH; Hyung WJ;
Ann Surg Oncol; 2010 Jul; 17(7):1777-86. PubMed ID: 20151217
[TBL] [Abstract][Full Text] [Related]
13. Group I pepsinogen for early detection of gastric cancer recurrence after total gastrectomy.
Kodama M; Koyama K; Tsuburaya Y; Ishikawa K; Koyama H; Narisawa T; Uesaka Y
World J Surg; 1990; 14(1):94-9; discussion 99-100. PubMed ID: 2305591
[TBL] [Abstract][Full Text] [Related]
14. Preoperative CA 125 is significant indicator of curative resection in gastric cancer patients.
Kim DH; Yun HY; Ryu DH; Han HS; Han JH; Yoon SM; Youn SJ
World J Gastroenterol; 2015 Jan; 21(4):1216-21. PubMed ID: 25632195
[TBL] [Abstract][Full Text] [Related]
15. Recurrence in patients following curative resection of early gastric carcinoma.
Wu B; Wu D; Wang M; Wang G
J Surg Oncol; 2008 Nov; 98(6):411-4. PubMed ID: 18767119
[TBL] [Abstract][Full Text] [Related]
16. Early detection of nonperitoneal recurrence may contribute to survival benefit after curative gastrectomy for gastric cancer.
Fujiya K; Tokunaga M; Makuuchi R; Nishiwaki N; Omori H; Takagi W; Hirata F; Hikage M; Tanizawa Y; Bando E; Kawamura T; Terashima M
Gastric Cancer; 2017 Mar; 20(Suppl 1):141-149. PubMed ID: 27778124
[TBL] [Abstract][Full Text] [Related]
17. bcl-2 protein expression in gastric remnant mucosa and gastric cancer 15 or more years after partial gastrectomy.
Clarke MR; Safatle-Ribeiro AV; Ribeiro U; Sakai P; Reynolds JC
Mod Pathol; 1997 Oct; 10(10):1021-7. PubMed ID: 9346182
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating cancer cells after a gastrectomy for gastric cancer.
Ikeguchi M; Kaibara N
Surg Today; 2005; 35(6):436-41. PubMed ID: 15912289
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of PCR-based identification of isolated tumour cells in the peritoneal lavage fluid of gastric cancer patients who underwent a curative R0 resection.
Katsuragi K; Yashiro M; Sawada T; Osaka H; Ohira M; Hirakawa K
Br J Cancer; 2007 Aug; 97(4):550-6. PubMed ID: 17667927
[TBL] [Abstract][Full Text] [Related]
20. The prognostic analysis of lymph node-positive gastric cancer patients following curative resection.
Deng J; Liang H; Sun D; Pan Y
J Surg Res; 2010 Jun; 161(1):47-53. PubMed ID: 19783008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
